Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in C-peptide Positive Type 1 Diabetes
NCT02617654Phase 2Completed
- Sponsor
- Per-Ola Carlsson
- Start
- Nov 2015
- Primary completion
- Sep 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Per-Ola Carlsson. Started Nov 2015; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02617654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617654.